BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 297 filers reported holding BIONTECH SE in Q2 2022. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $91,258 | +43.3% | 840 | +42.4% | 0.00% | – |
| Q2 2023 | $63,679 | -17.8% | 590 | -5.1% | 0.00% | – |
| Q1 2023 | $77,495 | -18.6% | 622 | -1.9% | 0.00% | – |
| Q4 2022 | $95,254 | -36.1% | 634 | -42.7% | 0.00% | – |
| Q3 2022 | $149,000 | -10.2% | 1,106 | -0.9% | 0.00% | – |
| Q2 2022 | $166,000 | +3.8% | 1,116 | +19.2% | 0.00% | – |
| Q1 2022 | $160,000 | -76.0% | 936 | -63.8% | 0.00% | -100.0% |
| Q4 2021 | $666,000 | +11.7% | 2,584 | +18.3% | 0.00% | 0.0% |
| Q3 2021 | $596,000 | +297.3% | 2,184 | +226.0% | 0.00% | – |
| Q2 2021 | $150,000 | +89.9% | 670 | -6.9% | 0.00% | – |
| Q1 2021 | $79,000 | -44.8% | 720 | -59.1% | 0.00% | – |
| Q4 2020 | $143,000 | +297.2% | 1,760 | +238.5% | 0.00% | – |
| Q3 2020 | $36,000 | +2.9% | 520 | 0.0% | 0.00% | – |
| Q2 2020 | $35,000 | – | 520 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |